Phraxis, Inc Seeking FDA 510(k) Clearance for InterGraft
What if a graft did not have to be sewn to native blood vessels, but could just open up veins for dialysis through a pinprick? That's what Phraxis has obtained Series D funding to do.
Read the full article » | Posted 05-12-2022
Related Articles
- Xeltis is Trialing its Polymer-based Vascular Access Posted 03-12-2026
- New Bluetooth-enabled CAPD System Enhanced Patient Satisfaction Posted 03-12-2026
- Emerging Biomarker Research in PD Posted 03-12-2026
- Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026